Asthma, Allergic Completed Phase 2 / 3 Trials for Omalizumab (DB00043)

Also known as: Atopic Asthma / Allergic Asthma / Asthma extrinsic / Extrinsic asthma / Asthma / Asthma, unspecified / Asthma bronchial / Asthma NOS / Asthmatic / Br. asthma / Bronchitic asthma

IndicationStatusPhase
DBCOND0047182 (Asthma, Allergic)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01976208Safety and Efficacy Study of Omalizumab to Treat Allergic AsthmaTreatment